Literature DB >> 661564

Relationship between the plasma glucose level and glucose uptake in the conscious dog.

A D Cherrington, P E Williams, M S Harris.   

Abstract

In the absence of a change in the pancreatic hormonal milieu, elevations in the normal fasting plasma glucose level have little effect on glucose clearance. In view of these data, and the previously established responsiveness of M to hormones, glucose clearance can be considered to represent a useful index of hormone action on glucose uptake in vivo. Care should be taken, however, when interpreting clearance data obtained under hypoglycemic conditions, since there is a possibility that clearance may spontaneously increase at very low plasma glucose levels.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 661564     DOI: 10.1016/0026-0495(78)90213-5

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  29 in total

Review 1.  Regulation of hepatic glucose uptake and storage in vivo.

Authors:  Mary Courtney Moore; Katie C Coate; Jason J Winnick; Zhibo An; Alan D Cherrington
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

2.  Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration.

Authors:  S R Myers; O P McGuinness; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

3.  Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.

Authors:  A Basu; A Alzaid; S Dinneen; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

Review 4.  The metabolic clearance of glucose: measurement and meaning.

Authors:  J Radziuk; H L Lickley
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

5.  Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients.

Authors:  A Golay; R A DeFronzo; E Ferrannini; D C Simonson; D Thorin; K Acheson; D Thiébaud; B Curchod; E Jéquier; J P Felber
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

6.  Insulin secretion and insulin sensitivity defects are a common feature of mild, clinically homogeneous, recently diagnosed type II (non-insulin-dependent) diabetics.

Authors:  E Pisu; A Lombardi; D De Benedictis; C Bozzo; E Chiara; C Baggiore; A Bruno; L Cravero; G Pagano; G Lenti
Journal:  Acta Diabetol Lat       Date:  1986 Jul-Sep

7.  Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.

Authors:  Robert A Rizza
Journal:  Diabetes       Date:  2010-08-12       Impact factor: 9.461

8.  Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.

Authors:  N Eigler; L Saccà; R S Sherwin
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

9.  Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.

Authors:  S Dinneen; A Alzaid; J Miles; R Rizza
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Effects of antecedent GABAA activation with alprazolam on counterregulatory responses to hypoglycemia in healthy humans.

Authors:  Maka S Hedrington; Stephnie Farmerie; Andrew C Ertl; Zhihui Wang; Donna B Tate; Stephen N Davis
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.